Cancer Registry Software Market to grow by USD 82.3 million from 2022-2027, North America to account for 51% of market growth- Technavio

NEW YORK, Sept. 13, 2023 /PRNewswire/ — The cancer registry software market size is expected to grow by USD 82.3 million from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 12.13% during the forecast period, according to Technavio Research. The market has been segmented by End-user (Government and third party, Pharma biotech and medical device company, Hospitals and medical practice, Private payers, and Research institutes), Type (Stand-alone software and Integrated software), and Geography (North America, Europe, Asia, and Rest of World (ROW)). North America will contribute 51% to the growth of the global market during the forecast period. The majority of the market growth in this region is driven by the high adoption of technology, increasing burden of cancer cases, favorable government funding to encourage the development of cancer registries, growing investments in information technology in healthcare, and rising focus on value-based care. In addition, the increasing presence of prominent vendors and the use of EHRs in hospitals are driving the growth of the cancer registry software market in North America. The US and Canada are the key markets for cancer registry software in North America. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read FREE PDF Sample Report

Company Profile:

CDC, Conduent Inc., Elekta AB, ERS Inc., Inspirata Inc., International Association of Cancer Registries, International Business Machines Corp., McKesson Corp., NeuralFrame Inc., OMH HealthEdge Holdings LLC, Onco Inc., Ordinal Data Inc., Redsson Ltd., Siemens Healthineers AG, University of Utah Health

CDC: The company offers cancer registry software such as Registry Plus.

To gain access to more vendor profiles available with Technavio, buy the report!

Cancer Registry Software Market: Segmentation Analysis

By Segment – The government and third-party segments will be significant during the forecast period. Such software solutions are designed to help government hospitals and third-party agencies collect, manage, and analyze data on cancer cases. Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report

“Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021”- Technavio

Cancer Registry Software Market: Driver & Trend:

Driver

Growing prevalence of cancer cases
Growing number of cancer registries
Increasing partnerships to improve cancer registries

The growing prevalence of cancer cases is one of the key factors likely to drive the market positively during the forecast period. Medical researchers need up-to-date data related to cancer such as population diagnosed with cancer, patients undergoing treatment, and mortality rate to monitor trends and study the possible causes of cancer. Breast, cervical, and prostate cancers are highly prevalent among the population in the US and European countries. Healthcare providers need data related to cancer incidences for decision-making regarding the volume of equipment and medicines to be purchased for treatment and awareness. These factors will further drive the cancer registry software market’s growth during the forecast period.

Identify key trends, drivers, and challenges in the market. Download FREE sample to gain access to this information.

Related Reports:

The Global Cancer Diagnostics Market size is estimated to grow at a CAGR of 11.3% between 2022 and 2027. The market size is forecast to increase by USD 12,626.21 million. This cancer diagnostics market report extensively covers market segmentation by end-user (hospitals and clinics, and diagnostic laboratories), type (IVD, imaging, and IDT), and geography (North America, Europe, APAC, and Rest of World (ROW)). One of the key factors driving the global cancer diagnostics market growth is the high prevalence of cancer.

The cancer immunotherapy market is estimated to grow by USD 38.57 billion at a CAGR of 7.42% between 2022 and 2027. Technavio has segmented the market into Type, Application, and Geography. The type is classified into monoclonal antibodies, checkpoint inhibitors and immunomodulators, and cancer vaccines. The application is classified into lung cancer, breast cancer, colorectal cancer, and others. The geography segment includes key regions such as North America, Europe, Asia, and the Rest of World (ROW)

What are the key data covered in this cancer registry software market report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the cancer registry software market between 2022 and 2027.
Precise estimation of the cancer registry software market size and its contribution to the market in focus on the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market across North America, Europe, Asia, and ROW
A thorough analysis of the market’s competitive landscape and detailed information about vendors
Comprehensive analysis of factors that will challenge the growth of cancer registry software market vendors.

ToC:

Executive Summary

Market Landscape

Market Sizing

Historic Market Sizes

Five Forces Analysis

Market Segmentation by End-user

Market Segmentation by Type

Market Segmentation by Geography

Customer Landscape

Geographic Landscape

Drivers, Challenges, & Trends

Company Landscape

Company Analysis

Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: [email protected]

Website: www.technavio.com